La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cencora Croissance future
Future contrôle des critères 2/6
Cencora devrait augmenter ses bénéfices et son chiffre d'affaires de 11.3% et de 6.9% par an respectivement. Le BPA devrait croître de de 14% par an. Le rendement des capitaux propres devrait être 98.7% dans 3 ans.
Informations clés
11.3%
Taux de croissance des bénéfices
14.0%
Taux de croissance du BPA
Healthcare croissance des bénéfices | 19.3% |
Taux de croissance des recettes | 6.9% |
Rendement futur des capitaux propres | 98.6% |
Couverture par les analystes | Good |
Dernière mise à jour | 21 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings
Jul 16Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning
Jun 30Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?
Jun 28Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Jun 09Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?
May 21Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings
Apr 05Cencora Remains Chronically Undervalued, With Material Growth Potential
Mar 25Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 18Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly
Feb 25Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Feb 07Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price
Jan 05Cencora: Continued Economic Value On The Table Across All Investment Horizons
Jan 04A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)
Dec 15Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year
Nov 05Is Cencora (NYSE:COR) A Risky Investment?
Nov 03Cencora: New Name, Same Old Economic Leverage, Reiterate Buy
Oct 18AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate
Aug 01AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)
Jul 28We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt
Jun 19Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?
May 01Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching
Apr 10AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet
Mar 02AmerisourceBergen declares $0.485 dividend
Feb 01AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Jan 28AmerisourceBergen partners with pharmaceutical company Civica
Jan 23AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?
Jan 13Does AmerisourceBergen (NYSE:ABC) Deserve A Spot On Your Watchlist?
Jan 10AmerisourceBergen sued by DoJ over suspicious opioid orders
Dec 29Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
9/30/2026 | 334,144 | 2,530 | 3,345 | 3,898 | 14 |
9/30/2025 | 313,474 | 2,274 | 2,883 | 3,443 | 15 |
9/30/2024 | 292,609 | 2,030 | 2,626 | 3,059 | 14 |
6/30/2024 | 283,831 | 1,856 | 3,831 | 4,311 | N/A |
3/31/2024 | 276,537 | 1,852 | 2,112 | 2,578 | N/A |
12/31/2023 | 271,579 | 1,867 | 3,630 | 4,086 | N/A |
9/30/2023 | 262,173 | 1,745 | 3,453 | 3,911 | N/A |
6/30/2023 | 254,425 | 1,689 | 2,793 | 3,249 | N/A |
3/31/2023 | 247,543 | 1,617 | 2,447 | 2,913 | N/A |
12/31/2022 | 241,805 | 1,729 | 2,057 | 2,550 | N/A |
9/30/2022 | 238,587 | 1,699 | 2,207 | 2,703 | N/A |
6/30/2022 | 236,325 | 1,842 | 2,061 | 2,548 | N/A |
3/31/2022 | 229,666 | 1,727 | 2,851 | 3,347 | N/A |
12/31/2021 | 221,101 | 1,614 | 2,174 | 2,627 | N/A |
9/30/2021 | 213,989 | 1,540 | 2,228 | 2,667 | N/A |
6/30/2021 | 204,321 | -3,744 | 2,564 | 2,956 | N/A |
3/31/2021 | 196,282 | -3,747 | 1,284 | 1,660 | N/A |
12/31/2020 | 194,546 | -3,222 | 2,600 | 2,967 | N/A |
9/30/2020 | 189,894 | -3,409 | 1,837 | 2,207 | N/A |
6/30/2020 | 186,287 | 1,570 | 1,250 | 1,581 | N/A |
3/31/2020 | 186,159 | 1,582 | 1,943 | 2,236 | N/A |
12/31/2019 | 182,061 | 649 | 1,710 | 2,008 | N/A |
9/30/2019 | 179,589 | 855 | 2,034 | 2,344 | N/A |
6/30/2019 | 177,248 | 956 | 2,018 | 2,337 | N/A |
3/31/2019 | 175,151 | 930 | 2,263 | 2,592 | N/A |
12/31/2018 | 172,866 | 1,190 | 1,538 | 1,880 | N/A |
9/30/2018 | 167,940 | 1,658 | 1,075 | 1,411 | N/A |
6/30/2018 | 163,763 | 1,081 | 1,783 | 2,126 | N/A |
3/31/2018 | 159,327 | 855 | N/A | 1,059 | N/A |
12/31/2017 | 155,441 | 979 | N/A | 1,945 | N/A |
9/30/2017 | 153,144 | 364 | N/A | 1,504 | N/A |
6/30/2017 | 151,584 | 855 | N/A | 1,478 | N/A |
3/31/2017 | 149,759 | 1,154 | N/A | 1,915 | N/A |
12/31/2016 | 148,310 | 1,346 | N/A | 1,997 | N/A |
9/30/2016 | 146,850 | 1,428 | N/A | 3,178 | N/A |
6/30/2016 | 144,759 | 1,643 | N/A | 2,986 | N/A |
3/31/2016 | 142,111 | 1,508 | N/A | 3,916 | N/A |
12/31/2015 | 139,082 | 391 | N/A | 3,777 | N/A |
9/30/2015 | 135,962 | -138 | N/A | 3,922 | N/A |
6/30/2015 | 132,080 | -431 | N/A | 3,591 | N/A |
3/31/2015 | 128,195 | -658 | N/A | 2,989 | N/A |
12/31/2014 | 123,981 | 35 | N/A | 3,364 | N/A |
9/30/2014 | 119,569 | 282 | N/A | 1,465 | N/A |
6/30/2014 | 112,449 | 267 | N/A | 602 | N/A |
3/31/2014 | 104,008 | 344 | N/A | 157 | N/A |
12/31/2013 | 96,076 | 368 | N/A | 26 | N/A |
9/30/2013 | 87,959 | 493 | N/A | 788 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de COR ( 11.3% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de COR ( 11.3% par an) devraient croître plus lentement que le marché US ( 15.1% par an).
Croissance élevée des bénéfices: Les bénéfices de COR devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de COR ( 6.9% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de COR ( 6.9% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de COR devrait être très élevé dans 3 ans ( 98.7 %).